Jane Street’s Oramed Pharmaceuticals ORMP Stock Holding History

Jane Street’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-29,900	Closed	-$360K	–	9682
2022 Q4	$360K	Buy	+29,900	New	+$232K	﹤0.01%	6701
2022 Q2	–	Sell	-12,800	Closed	-$111K	–	10525
2022 Q1	$111K	Sell	12,800 -8,400	-40%	-$86.1K	﹤0.01%	9404
2021 Q4	$303K	Sell	21,200 -27,100	-56%	-$567K	﹤0.01%	8150
2021 Q3	$1.06M	Buy	48,300 +22,900	+90%	+$390K	﹤0.01%	5790
2021 Q2	$340K	Buy	+25,400	New	+$291K	﹤0.01%	7933

Other funds holding ORMP

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jane Street's ORMP Position: Q2 2026 in Review

Jane Street increased its Oramed Pharmaceuticals (ORMP) stake by 116% in Q2 2026, buying an estimated $242K and bringing the position to 113,349 shares worth $545K. The position accounts for ﹤0.01% of the portfolio, ranked #7809.

Jane Street first reported a position in ORMP in Q1 2014 and has held it in 28 quarters since. The position peaked at $1.6M in Q4 2022. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

Jane Street held 113,349 shares of Oramed Pharmaceuticals worth $545K as of Q2 2026.
Jane Street bought 60,809 Oramed Pharmaceuticals shares in Q2 2026, an estimated $242K.
Oramed Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7809 holding.
Jane Street first reported a position in Oramed Pharmaceuticals in Q1 2014 and has held it in 28 quarters since.
Jane Street's Oramed Pharmaceuticals position peaked at $1.6M in Q4 2022.
84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.